These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34143867)

  • 1. Twenty-Four-Hour Ambulatory Blood Pressure Measurement Using a Novel Noninvasive, Cuffless, Wireless Device.
    Nachman D; Gilan A; Goldstein N; Constantini K; Littman R; Eisenkraft A; Grossman E; Gepner Y
    Am J Hypertens; 2021 Nov; 34(11):1171-1180. PubMed ID: 34143867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the ability of a commercially available cuffless wearable device to track blood pressure changes.
    Tan I; Gnanenthiran SR; Chan J; Kyriakoulis KG; Schlaich MP; Rodgers A; Stergiou GS; Schutte AE
    J Hypertens; 2023 Jun; 41(6):1003-1010. PubMed ID: 37016925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Method-comparison study between a watch-like sensor and a cuff-based device for 24-h ambulatory blood pressure monitoring.
    Proença M; Ambühl J; Bonnier G; Meister TA; Valentin J; Soria R; Ferrario D; Lemay M; Rexhaj E
    Sci Rep; 2023 Apr; 13(1):6149. PubMed ID: 37061569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and Acceptability of a Cuffless Wrist-Worn Wearable Blood Pressure Monitoring Device Among Users and Health Care Professionals: Mixed Methods Study.
    Islam SMS; Cartledge S; Karmakar C; Rawstorn JC; Fraser SF; Chow C; Maddison R
    JMIR Mhealth Uhealth; 2019 Sep; 7(10):e14706. PubMed ID: 31628788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulse Arrival Time Based Cuff-Less and 24-H Wearable Blood Pressure Monitoring and its Diagnostic Value in Hypertension.
    Zheng Y; Poon CC; Yan BP; Lau JY
    J Med Syst; 2016 Sep; 40(9):195. PubMed ID: 27447469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension in young patients after renal transplantation: ambulatory blood pressure monitoring versus casual blood pressure.
    Calzolari A; Giordano U; Matteucci MC; Pastore E; Turchetta A; Rizzoni G; Alpert B
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):497-501. PubMed ID: 9607390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.
    Ravenell J; Shimbo D; Booth JN; Sarpong DF; Agyemang C; Beatty Moody DL; Abdalla M; Spruill TM; Shallcross AJ; Bress AP; Muntner P; Ogedegbe G
    Circulation; 2017 Jun; 135(25):2470-2480. PubMed ID: 28428231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
    Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
    Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the utility of ambulatory blood pressure monitoring in kidney transplant recipients.
    Wen KC; Gourishankar S
    Clin Transplant; 2012; 26(5):E465-70. PubMed ID: 23061756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cuff-based and cuffless continuous blood pressure measurements in children and adolescents.
    Zachwieja J; Neyman-Bartkowiak A; Rabiega A; Wojciechowska M; Barabasz M; Musielak A; Silska-Dittmar M; Ostalska-Nowicka D
    Clin Exp Hypertens; 2020 Aug; 42(6):512-518. PubMed ID: 31941385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of Peridialytic, Intradialytic, and Scheduled Interdialytic Recordings in Detecting Elevated Ambulatory Blood Pressure in Hemodialysis Patients.
    Sarafidis P; Theodorakopoulou MP; Loutradis C; Iatridi F; Alexandrou ME; Karpetas A; Koutroumpas G; Raptis V; Ferro CJ; Papagianni A
    Am J Kidney Dis; 2021 Nov; 78(5):630-639.e1. PubMed ID: 33857534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three Hours Ambulatory Blood Pressure: A Surrogate for Daytime Ambulatory Blood Pressure Assessment in the Pakistani Population.
    Shahab H; Khan HS; Tufail M; Artani A; Almas A; Shah HA; Khan AH
    Cureus; 2021 Aug; 13(8):e17433. PubMed ID: 34589341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
    Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH
    Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cuffless SOMNOtouch NIBP device shows poor agreement with a validated oscillometric device during 24-h ambulatory blood pressure monitoring.
    Nyvad J; Christensen KL; Buus NH; Reinhard M
    J Clin Hypertens (Greenwich); 2021 Jan; 23(1):61-70. PubMed ID: 33350030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous Monitoring of Blood Pressure Using a Wrist-Worn Cuffless Device.
    Sayer G; Piper G; Vorovich E; Raikhelkar J; Kim GH; Rodgers D; Shimbo D; Uriel N
    Am J Hypertens; 2022 May; 35(5):407-413. PubMed ID: 35171213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.